$173 Million is the total value of Essex Woodlands Management, Inc.'s 7 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDXG | MIMEDX GROUP, INC. | $79,847,141 | +22.7% | 23,415,584 | 0.0% | 46.20% | +27.3% | |
| TELA | TELA BIO, INC. | $43,737,944 | -7.5% | 4,110,709 | 0.0% | 25.31% | -4.0% | |
| RVNC | REVANCE THERAPEUTICS INC | $14,722,708 | +74.5% | 457,085 | 0.0% | 8.52% | +81.1% | |
| BVS | BIOVENTUS | $12,943,471 | -59.0% | 12,096,702 | 0.0% | 7.49% | -57.5% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $12,321,308 | -16.0% | 4,190,921 | 0.0% | 7.13% | -12.8% | |
| VERO | VENUS CONCEPT, INC. | $6,862,990 | -31.6% | 31,337,856 | 0.0% | 3.97% | -29.0% | |
| MNOV | MEDICINOVA INC | $2,388,833 | +5.4% | 1,105,941 | 0.0% | 1.38% | +9.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.